Standout Papers
Immediate Impact
1 by Nobel laureates 1 from Science/Nature 60 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Vivek Kumar being referenced
The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature
2020
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Vivek Kumar | 704 | 159 | 196 | 199 | 59 | 1.1k | |
| Sandra J. Casak | 433 | 187 | 143 | 108 | 31 | 964 | |
| Senji Kasahara | 426 | 117 | 417 | 214 | 85 | 1.3k | |
| Zhongjun Xia | 779 | 136 | 487 | 273 | 73 | 1.3k | |
| Nelly G. Adel | 899 | 146 | 87 | 136 | 26 | 1.4k | |
| Kyoung Ha Kim | 316 | 176 | 158 | 94 | 68 | 909 | |
| Ulas D. Bayraktar | 275 | 138 | 174 | 151 | 43 | 1.1k | |
| Miriam Tao | 469 | 69 | 468 | 232 | 58 | 922 | |
| Frank S. Fan | 349 | 359 | 191 | 291 | 84 | 1.4k | |
| İbrahim Barışta | 535 | 64 | 499 | 146 | 72 | 1.2k | |
| David Prager | 551 | 324 | 226 | 122 | 39 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...